Healthcare provider profile · identity verified

Christopher Keith Whipple

Hospitalist · NEW ORLEANS, LA · NPI 1003181306

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	644	96
Eliquis	Apixaban	500	41
Amlodipine Besylate	Amlodipine Besylate	339	52
Levothyroxine Sodium	Levothyroxine Sodium	261	33
Donepezil Hcl	Donepezil Hcl	255	32
Furosemide	Furosemide	236	48
Tamsulosin Hcl	Tamsulosin Hcl	229	37
Pantoprazole Sodium	Pantoprazole Sodium	220	43
Potassium Chloride	Potassium Chloride	210	39
Carvedilol	Carvedilol	196	32
Gabapentin	Gabapentin	187	29
Memantine Hcl	Memantine Hcl	183	26
Lisinopril	Lisinopril	178	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	177	36
Metoprolol Tartrate	Metoprolol Tartrate	154	25
Metformin Hcl	Metformin Hcl	150	20
Losartan Potassium	Losartan Potassium	149	22
Novolog Flexpen	Insulin Aspart	148	30
Sertraline Hcl	Sertraline Hcl	147	24
Quetiapine Fumarate	Quetiapine Fumarate	146	29
Mirtazapine	Mirtazapine	137	25
Trazodone Hcl	Trazodone Hcl	125	26
Clopidogrel	Clopidogrel Bisulfate	118	23
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	116	30
Famotidine	Famotidine	114	24
Escitalopram Oxalate	Escitalopram Oxalate	111	17
Duloxetine Hcl	Duloxetine Hcl	110	17
Latanoprost	Latanoprost	107	17
Ondansetron Hcl	Ondansetron Hcl	100	51
Fluticasone Propionate	Fluticasone Propionate	98	23
Januvia	Sitagliptin Phosphate	98	suppressed
Metoprolol Succinate	Metoprolol Succinate	96	16
Divalproex Sodium	Divalproex Sodium	95	14
Cyproheptadine Hcl	Cyproheptadine Hcl	91	17
Levetiracetam	Levetiracetam	89	18
Rosuvastatin Calcium	Rosuvastatin Calcium	87	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	81	14
Farxiga	Dapagliflozin Propanediol	74	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	73	19
Amiodarone Hcl	Amiodarone Hcl	69	suppressed
Metformin Hcl Er	Metformin Hcl	66	suppressed
Rexulti	Brexpiprazole	66	suppressed
Jardiance	Empagliflozin	64	11
Omeprazole	Omeprazole	64	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	63	32
Simvastatin	Simvastatin	62	suppressed
Aripiprazole	Aripiprazole	59	12
Hydralazine Hcl	Hydralazine Hcl	58	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	suppressed
Meloxicam	Meloxicam	57	suppressed
Baclofen	Baclofen	56	11
Nifedipine Er	Nifedipine	55	suppressed
Ezetimibe	Ezetimibe	53	suppressed
Irbesartan	Irbesartan	51	suppressed
Montelukast Sodium	Montelukast Sodium	49	suppressed
Spironolactone	Spironolactone	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Allopurinol	Allopurinol	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Gemtesa	Vibegron	44	suppressed
Levofloxacin	Levofloxacin	44	25
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	13
Topiramate	Topiramate	41	suppressed
Xarelto	Rivaroxaban	41	suppressed
Haloperidol	Haloperidol	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	37	suppressed
Insulin Aspart Flexpen	Insulin Aspart	35	12
Lactulose	Lactulose	35	12
Doxycycline Hyclate	Doxycycline Hyclate	34	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	34	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	34	15
Sodium Chloride	0.9 % Sodium Chloride	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Prednisolone Acetate	Prednisolone Acetate	33	suppressed
Finasteride	Finasteride	32	suppressed
Linzess	Linaclotide	32	suppressed
Midodrine Hcl	Midodrine Hcl	32	suppressed
Glipizide	Glipizide	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Olanzapine	Olanzapine	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	20
Bumetanide	Bumetanide	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Megestrol Acetate	Megestrol Acetate	27	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	27	11
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Loperamide	Loperamide Hcl	25	12
Lubiprostone	Lubiprostone	25	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	25	suppressed
Myrbetriq	Mirabegron	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Meropenem	Meropenem	23	suppressed
Risperidone	Risperidone	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Mupirocin	Mupirocin	22	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Atenolol	Atenolol	20	suppressed
Colchicine	Colchicine	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Azithromycin	Azithromycin	19	15
Prednisone	Prednisone	19	13
Amantadine	Amantadine Hcl	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Calcium Acetate	Calcium Acetate	17	suppressed
Cephalexin	Cephalexin	17	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Carbamazepine	Carbamazepine	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Lidocaine Hcl	Lidocaine Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	16
Nitroglycerin	Nitroglycerin	16	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Alphagan P	Brimonidine Tartrate	15	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	15	suppressed
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Ertapenem	Ertapenem Sodium	15	suppressed
Glycopyrrolate	Glycopyrrolate	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Cabergoline	Cabergoline	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nystatin	Nystatin	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error